Scarica l'app Stockscreener
24.77
4.65%
1.10
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
44.64%
9.043
|
6.252 | 13.58 | 7.894 | 44.06 |
| Operating Expenses |
4.56%
103.25
|
98.75 | 96.67 | 99.28 | 92.38 |
| Depreciation and Amortization |
2.69%
2.255
|
2.196 | 2.12 | 2.028 | 2.242 |
| Operating Income/Loss |
1.85%
-94.20
|
-92.50 | -83.09 | -91.39 | -48.32 |
| Income/Loss From Continuing Operations Before Tax |
-89.81
|
- | -78.22 | -86.42 | -42.70 |
| Income Tax Expense/Benefit |
-0.271
|
- | - | - | 0.76 |
| Net Income/Loss |
2.71%
-89.53
|
-87.17 | -78.22 | -86.42 | -43.46 |
| Basic Average Shares |
0.92%
111.08
|
110.07 | 2.7974 | 84.16 | 83.88 |
| Diluted Average Shares |
0.92%
111.08
|
110.07 | 2.7974 | 84.16 | 83.88 |
| Basic Earnings Per Share |
2.53%
-0.81
|
-0.79 | -0.83 | -1.03 | -0.52 |
| Diluted Earnings Per Share |
2.53%
-0.81
|
-0.79 | -0.83 | -1.03 | -0.52 |
| Common Stock Dividends |
-
|
- | - | - | - |
4.82%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):